BioSpace News Archive

Olema Oncology, a clinical-stage biopharmaceutical company focused on the discovery and development of targeted therapies for women’s cancers, today announced it has strengthened its executive team with the appointment of Shane Kovacs , M.B.A., as Chief Operating Officer/Chief Financial Officer, Kinney Horn as Chief Business O

Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provides painless and precise injections, announced that Leonard Osser, Interim Chief Executive Officer, will share insight into the company’s recent developments and upcoming milestones during an investor webinar on Monday, September 14, 2020 at 4:00 p.m. ET.

Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Dr. Drew as Senior Advisor, AditxtScore™, effective September 1, 2020.

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on liver-directed treatment of rare primary and metastatic cancers, today announced management will participate in two upcoming virtual investor conferences

Cerner Corporation, a global health care technology company, announced a collaboration with Finland regional leadership that is expected to deliver more coordinated and efficient access to health and social services through a government-sponsored set of standards.

Smiths Medical, a leading global medical device manufacturer, announced that University Health System in San Antonio, Texas has gone live with the PharmGuard® Infusion Management Software System with Bi-Directional Interoperability with Epic.

BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the Company will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 at 11:45 a.m. ET. A live webcast can be accessed from the investors section of BeiGene’s website at http:

The American College of Cardiology, in partnership with Novo Nordisk Inc., is launching Transforming Cardiovascular Risk in Diabetes (TRANSFORM CVRiD), a new, two-year health care quality initiative to promote cardiovascular risk reduction and care for people with Type 2 diabetes.

MJH Life Sciences™, the privately owned health care media company, is pleased to officially announce the MJH Life Sciences™ COVID-19 Coalition, an exciting new partnership with top health care thought leaders across a variety of medical disciplines.

The directors of Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, are pleased to announce the appointment of Mr Daniel Spiegelman as an independent Non-Executive Director, who will also serve as Chair of the Company’s Audit and Risk Committee, effective from September 10, 2020.